A phase 1b study of HC-7366 plus Welireg for advanced clear cell renal cell carcinoma has completed the dose escalation portion of the clinical trial.

Lymphovascular invasion is a pathologic feature commonly associated with aggressive renal cell carcinoma (RCC) and worse prognosis.

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 th and June 3 rd, 2025, was host to a kidney and bladder cancers oral abstract ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago, IL, was host to a kidney and bladder cancers oral abstract session. Dr. Tian Zhang discussed the ...

nucleoli are absent Clear-cell renal carcinoma with nuclei that vary in size and are generally larger than in grade I tumors; nucleoli are slightly visible and nuclear outlines are faintly irregular ...

Allogene Therapeutics Inc. (NASDAQ:ALLO) presented updated data from the Phase 1 TRAVERSE study of ALLO-316 in advanced or ...

Learning Objectives Understand the complexity of the tumor microenvironment Understand the issues in therapeutic strategies in Renal Cell Carcinoma Understand the immune cells essential for anti-tumor ...